South and Central America Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Procedure ; End User and Country

South and Central America Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Procedure ; End User and Country

  • November 2020 •
  • 138 pages •
  • Report ID: 5999810 •
  • Format: PDF
The South & Central America infertility treatment devices and equipment market is expected to reach US$ 108.35 million by 2027 from US$ 62.69 million in 2019. The market is estimated to grow at a CAGR of 7.2% from 2020-2027.
The growth of this market can be attributed to key driving factors such as a high rise in the infertility rate and increased support by the government to promote fertility. However, the lack of national regulatory bodies and stringent societal norms are likely to hamper the market growth.
Infertility is defined as not being able to get pregnant or conceive.It can be primary infertility (refers to couples who cannot become pregnant after at least 1 year having sex without using birth control methods) and secondary infertility (refers to couples who cannot get pregnant more than once).

There are many different infertility treatment devices and equipment options available for patients.Many factors are contributing to low fertility rate, thus in coming years, the number of patients seeking infertility treatment will raise.

Many companies have developed novel device and procedures for simple, effective and cost effective fertility treatment.
Infertility is one of the major reproductive health disorders affecting a high proportion of the population worldwide.Global infertility prevalence rates are difficult to estimate due to multiple factors.

However, according to the Demographic and Health Survey, one in every four couples in low-middle income countries are affected by infertility.It has been estimated that the number of infertile people in the world may be as high as 15%, particularly in industrialized countries.

Also, it is estimated that the prevalence of infertility would grow in the coming years, considering that lifestyle factors—such as alcohol consumption, smoking, obesity, lack of physical activity, and sexually transmitted diseases—which interfere negatively in female and male fertility, are increasing in the general population.According to the Latin American Network of Assisted Reproduction, most initiated cycles of assisted reproductive techniques were reported by Brazil, representing 44% of all cycles, followed by Argentina and Mexico, with 23% and 13%, respectively.

In 2013, data from the 7th Report of the Brazilian Embryo Production System showed that 24,147 initiated cycles of ART were produced with essential differences between Brazilian regions: 66% of these procedures were performed in ART clinics situated in the Southeast region and only 1% in the Northern region of the country. However, with access to 512 cycles per million women aged 15–45 years, Brazil is far behind high-income countries. Thus, a high rise in the infertility rate is driving the growth of the infertility treatment devices and equipment market.
South and Central America are among the regions with rising number of reported cases of COVID-19.As per the data of Worldometer, Brazil reported a total of 4,970,953 COVID-19 instances, and Argentina recorded 824,468 counts as of October 7, 2020.

Deaths reported in Brazil were 147,571, and in Argentina, the death toll was 21,827.They have responded to the situation by closing borders, ordering quarantines, avoiding alternative surgery procedures, and imposing a number of restrictions to keep people confined at home.

For instance, according to report of April-June 2020, in Brazil, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles due to pathogenesis of SARS-CoV-2 during pregnancy. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments.
Based on product, the infertility treatment devices and equipment market is segmented into ovum aspiration pumps, sperm separation devices, sperm analyzer systems, micromanipulator systems, incubators, and others.The ovum aspiration pumps segment held the largest share of the market in 2019.

The same segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on procedure, the infertility treatment devices and equipment market is segmented into assisted reproductive technology, artificial insemination, and fertility surgery. The artificial insemination segment held the largest share of the market in 2019, whereas the assisted reproductive technology segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the infertility treatment devices and equipment market is segmented into fertility clinics, hospitals and other healthcare facilities, and clinical research institutes.The fertility clinics segment held the largest share of the market in 2019.

Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Some of the major primary and secondary sources for infertility treatment devices and equipment market included in the report are Demographic and Health Survey, Latin American Network of Assisted Reproduction, and Brazilian Federal Council of Medicine, among others.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.